Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells
- 20 August 2015
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 358 (1-2) , 101-106
Abstract
No abstract availableKeywords
Funding Information
- Grant Agency of Charles University (351011/2011)
- Research Program PRVOUK-P26/LF1/4
- Specific Academic Research Projects Competiton (254260020)
This publication has 38 references indexed in Scilit:
- Myasthenia Gravis: Paradox versus paradigm in autoimmunityJournal of Autoimmunity, 2014
- Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanismsJournal of Autoimmunity, 2014
- Status of the Thymectomy Trial for Nonthymomatous Myasthenia Gravis Patients Receiving PrednisoneAnnals of the New York Academy of Sciences, 2008
- Development of a Thymectomy Trial in Nonthymomatous Myasthenia Gravis Patients Receiving Immunosuppressive TherapyAnnals of the New York Academy of Sciences, 2003
- Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) [RETIRED]Neurology, 2000
- Treatment of myasthenia gravis with anti‐CD4 antibodyNeurology, 1994
- A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.Journal of Clinical Investigation, 1988
- Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.Journal of Clinical Investigation, 1988
- Myasthenia Gravis1988
- Effects of Thymectomy in Myasthenia GravisAnnals of Surgery, 1987